Sernova Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021
Market Capitalization	36	42	58	176	172	263
Market Cap Growth	-16.62%	-27.55%	-66.76%	2.10%	-34.68%	534.77%
Enterprise Value	39	46	55	153	141	239
Last Close Price	0.11	0.11	0.18	0.57	0.59	0.99
PB Ratio	-2.02	-2.36	-6.28	19.49	4.93	11.63
P/TBV Ratio	-	-	-	19.99	4.98	11.93
Debt / Equity Ratio	-0.19	-0.19	-0.04	0.01	0.01	0.01
Quick Ratio	0.02	0.02	0.32	2.17	10.74	19.19
Current Ratio	0.02	0.02	0.32	2.19	10.78	19.19
Return on Equity (ROE)	-	-	-	-129.72%	-64.54%	-43.25%
Return on Assets (ROA)	-226.48%	-226.48%	-133.56%	-67.87%	-37.59%	-24.39%
Return on Capital Employed (ROCE)	62.50%	62.50%	253.60%	-323.60%	-51.80%	-24.50%
Earnings Yield	-31.05%	-26.57%	-39.58%	-15.99%	-10.41%	-2.13%
FCF Yield	-	-18.41%	-23.23%	-12.48%	-6.29%	-2.10%
Buyback Yield / Dilution	-6.95%	-6.95%	-1.19%	-10.87%	-11.43%	-24.45%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.